Skip to content
Menu

Pharma Mar, S.A. PHMMF

Full chart Compare
Set alert

Price alert · PHMMF

All alert types
66.95 USD 0.00 (+0.00%)

Regular-session close

75.05 Day range 75.05
66.95 52-week range 106.48
YTD
-22.39%
1 year
-22.48%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

6.42 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B3 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 2
  • P/E 2
  • P/B 1

Valuation

P/E 17.1×
P/S 5.7×
P/B 5.0×
P/FCF 28.9×
EV/EBITDA 26.8×
EV/Sales 5.9×
FCF Yield 3.5%

Profitability

Gross Margin 94.5%
Operating Margin 18.2%
Net Margin 33.9%
ROE 29.8%
ROIC 12.8%
ROA 19.0%

Growth (YoY)

Revenue 26.6%
Operating Income 522.5%
EPS (diluted) 188.6%
Free Cash Flow 561.2%

Financial Health

Current Ratio 3.0×
Quick Ratio 2.4×
Debt / Equity 0.2×
Net Debt / EBITDA 0.7×
Interest Coverage 16.4×

Dividends

Dividend Yield 1.1%
Payout Ratio 18.6%

Annual · latest fiscal year ends 2025-12-31